Fidelity Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $55.7K | Sell |
|
|||||
|
2023
Q4 | $58K | Buy |
|
|||||
|
2023
Q3 | $66K | Buy |
|
|||||
|
2023
Q2 | $125K | Buy |
|
|||||
|
2023
Q1 | $192K | Buy |
|
|||||
|
2022
Q4 | $233K | Sell |
|
|||||
|
2022
Q3 | $56.6M | Buy |
|
|||||
|
2022
Q2 | $26.4M | Buy |
|
|||||
|
2022
Q1 | $19.4M | Sell |
|
|||||
|
2021
Q4 | $23M | Sell |
|
|||||
|
2021
Q3 | $27.5M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3.99M | Hold |
|
|||||
|
2019
Q2 | $4.22M | Buy |
|